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Sensors in automated liquid culture systems for mycobacteria, such as MGIT, BacT/Alert 3D, and Trek ESP
II, flag growth of any type of bacteria; a positive signal does not mean that the target mycobacteria are present.
All signal-positive cultures thus require additional and often laborious testing. An immunoassay was developed
to screen liquid mycobacterial cultures for evidence of Mycobacterium avium complex (MAC). The method,
called the MAC–enzyme-linked immunosorbent assay (ELISA), relies on detection of MAC-specific secreted
antigens in liquid culture. Secreted MAC antigens were captured by the MAC-ELISA with polyclonal anti-
Mycobacterium avium subsp. paratuberculosis chicken immunoglobulin Y (IgY), detected using rabbit anti-MAC
IgG, and then revealed using horseradish peroxidase-conjugated goat anti-rabbit IgG. When the MAC-ELISA
was evaluated using pure cultures of known mycobacterial (n 75) and nonmycobacterial (n 17) organisms,
no false-positive or false-negative MAC-ELISA results were found. By receiver operator characteristic (ROC)
analysis of 1,275 previously identified clinical isolates, at the assay optimal cutoff the diagnostic sensitivity and
specificity of the MAC-ELISA were 92.6% (95% confidence interval [95% CI], 90.3 to 94.5) and 99.9% (95% CI,
99.2 to 100), respectively, with an area under the ROC curve of 0.992. Prospective evaluation of the MAC-
ELISA with an additional 652 clinical samples inoculated into MGIT ParaTB medium and signaling positive
per the manufacturer’s instructions found that the MAC-ELISA was effective in determining those cultures
that actually contained MAC species and warranting the resources required to identify the organism by PCR.
Of these 652 MGIT-positive cultures, the MAC-ELISA correctly identified 96.8% (of 219 MAC-ELISA-positive
cultures) as truly containing MAC mycobacteria, based on PCR or high-performance liquid chromatography
(HPLC) as reference tests. Only 6 of 433 MGIT signal-positive cultures (1.4%) were MAC-ELISA false
negative, and only 7 of 219 MGIT signal-negative cultures (3.2%) were false positive. The MAC-ELISA is a
low-cost, rapid, sensitive, and specific test for MAC in liquid cultures. It could be used in conjunction with or
independent of automated culture reading instrumentation. For maximal accuracy and subspecies-specific
identification, use of a confirmatory multiplex MAC PCR is recommended.
Members of the Mycobacterium avium complex (MAC) are
a family of intracellular bacterial pathogens causing significant
disease in both animals and humans. The complex contains
four subspecies of M. avium: M. avium subsp. avium, M. avium
subsp. paratuberculosis, M. avium subsp. hominissuis, and M.
avium subsp. silvaticum (24, 35). Mycobacterium intracellulare is
also a member of the complex (20, 35).
The clinical importance of MAC infection has increased in
recent decades because of the greater population of immuno-
compromised individuals with longer life expectancies, immu-
nosuppressive chemotherapy, and the spread of human immu-
nodeficiency virus infection (8, 20, 25, 27). With AIDS patients,
the incidence of disseminated mycobacterial infection caused
by MAC strains can reach up to 50% (19). Although these
mycobacterial infections are not often characterized to subspe-
cies, it appears that M. avium subsp. hominissuis is most often
involved with AIDS patients (3, 4, 18, 24, 35). In addition, M.
avium subsp. hominissuis causes infection in a subset of pa-
tients without an obvious immune defect (13) or underlying
pulmonary disease and in children with lymphadenitis or cystic
fibrosis (31). In virtually all cases, these organisms are believed
to be of environmental origin: surface water, tap water, soil,
dust, or food (22, 24, 29, 38). M. avium subsp. avium, ubiqui-
tous in the environment and more virulent than M. avium
subsp. hominissuis, is distinguished by the insertion element
IS901 (24). While capable of infecting multiple animal species,
M. avium subsp. avium is commonly isolated from birds as one
of the causes of avian tuberculosis (26, 32). M. avium subsp.
silvaticum, also called the “wood pigeon bacillus,” is uncom-
monly isolated but reported to cause enteritis in ruminants as
well as disseminated infection in other hosts (33).
M. avium subsp. paratuberculosis infection causes paratuber-
culosis (Johne’s disease) characterized by chronic granuloma-
tous enteritis in animals, most often ruminants (9, 21). This
organism grows very slowly in vitro (slower than most “slow-
growing” mycobacteria), is dependent on mycobactin for
growth in vitro, and is alone in containing IS900 in its genome
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(15, 16, 23). M. avium subsp. paratuberculosis has a broad host
range and is implicated by some in the pathogenesis of Crohn’s
disease in humans (1, 12). The inability of M. avium subsp.
paratuberculosis to produce the siderophore mycobactin ren-
ders it incapable of replication in the environment, with the
possible exception of inside free-living amoeba, and so it is
considered an obligate parasite of animals and possibly hu-
mans (6). Paratuberculosis has emerged as a common and
costly disease for the dairy industry (16). Surveys indicate that
at least 68% of U.S. dairy herds are M. avium subsp. paratu-
berculosis infected (36).
Microbiological culture remains a mainstay for diagnosis of
mycobacterial infections, since it has greater sensitivity than
PCR-based methods and yields the living isolates necessary for
antibiotic susceptibility testing and molecular epidemiology.
Because culture on conventional solid bacteriological media is
laborious and slow, liquid culture-based mycobacterial detec-
tion systems, such the Bactec, MGIT, Trek ESP, and BacT/
Alert 3D systems, have become commonplace in clinical lab-
oratories, offering the advantages of automation and shorter
detection times from clinical samples (5, 7, 17, 37). However, a
positive signal during culture with any of these systems is sim-
ply a nonspecific indication of any sort of microbial growth
(37). Thus, specimen processing and decontamination proto-
cols to selectively kill nonmycobacterial microflora in the clin-
ical or environmental samples are key components for an ef-
fective assay (7, 34). Although a number of different protocols
have been described (7, 11, 28, 34), a standard protocol spe-
cifically designed for optimal recovery of MAC has not yet
been established.
Numerous PCRs are performed in our laboratory in re-
sponse to these signal-positive cultures; in the last year, ap-
proximately 45% did not contain the pathogen of interest,
MAC (unpublished data). This sample management approach
is inefficient and labor-intensive.
To better focus PCR resources on those cultures most likely
to contain MAC, a novel enzyme-linked immunosorbent assay
(ELISA) was designed to detect secreted MAC antigens in
culture medium fluid. This assay, called the MAC-ELISA, was
then evaluated for analytical and diagnostic specificity and
sensitivity, first using pure cultures and then cultures derived
from clinical samples.
MATERIALS AND METHODS
Bacterial strains, cultures, and preparations of antigens. To develop a MAC
antigen-capture ELISA with anti-MAC antibody as the solid phase, a number of
organism cultures were prepared. MAC strains were selected to encompass the
most clinically important M. avium subspecies, using both type strains and clin-
ical strains. Antibodies were produced by immunization of rabbits (immunoglob-
ulin G [IgG]) and chickens (IgY) with M. avium subsp. paratuberculosis and
MAC culture filtrate antigens (CFA). All bacterial strains used for antibody
production and tested in this study are listed in Table 1. Briefly, M. avium subsp.
paratuberculosis ATCC 19698, M. avium subsp. paratuberculosis JTC114, and M.
avium subsp. paratuberculosis JTC303 were cultivated in modified Watson-Reid
(mWR) (pH 6.0) broth media supplemented with 2 g/ml of mycobactin J
(Allied Monitor, Fayette, MO). The static cultivation was performed by inocu-
lating 100 l of 109 CFU/ml seedlot culture into the cell culture flask (75 cm2;
canned neck; Corning Inc., NY) containing 50 ml of mWR broth medium for 10
weeks at 37°C in 5% CO2 humidified conditions.
M. avium subsp. paratuberculosis CFA were harvested and pooled as previously
described (30). M. avium subsp. avium strain ATCC 35712 and M. avium subsp.
hominissuis strain 104 were cultured in mWR for 6 weeks at 37°C to obtain and
pool MAC antigens.
Cellular extracts (CE) were used to remove by absorption cross-reactive an-
tibodies from the rabbit anti-MAC IgG and chicken anti-MAC IgY as previously
described (30). To prepare CE antigens (CEA), Mycobacterium intracellulare
ATCC 13950, M. intracellulare ATCC 25122, and Mycobacterium scrofulaceum
ATCC 19981 were cultivated in mWR broth for 4 weeks at 37°C. Mycobacterium
phlei ATCC 11758 and Mycobacterium terrae ATCC 15755 strains were cultivated
in mWR for 2 weeks at 37°C.
To evaluate antibody specificity, other non-MAC mycobacterial strains were
cultured in 7H9 broth supplemented with 10% OADC (oleic acid-albumin-
dextrose-catalase; Becton Dickinson, Sparks, MD) for 2 to 4 weeks at 37°C
(Table 1). Nonmycobacterial strains were grown in Luria-Bertani (LB) broth.
For preparation of CEA from each bacterium grown in mWR, 7H9 or LB
broth was prepared as previously described (30). The concentration of proteins
in each CFA and CEA preparation was determined by a bicinchoninic acid
(BCA) protein assay kit (Pierce, Rockford, IL).
Antibody production. MAC (two strains) and M. avium subsp. paratuberculosis
(three strains) antigen pools were made to immunize rabbits and chickens.
Briefly, 250 l of each antigen was pooled, adjusted to a final concentration of
1,000 g/ml, and stored as 1-ml aliquots at 20° until use. After mixing 250 l
of each filtrate, each pool was adjusted to a final concentration of 1,000 g/ml
and stored as 1-ml aliquots at 20° until use. A total of four chickens and four
rabbits were used for production of antibody, two each for anti-M. avium subsp.
paratuberculosis and anti-MAC.
At each immunization, laying chickens were inoculated with 500 l of CFA
mixed with an equal volume of Freund’s incomplete adjuvant (FIA). The first
immunization was given subcutaneously. Subsequent immunizations were given
intramuscularly, the first 2 weeks later and the remaining four at 1-week inter-
vals. Eggs from each hen were collected daily after the second immunization,
labeled, and stored at 4°C until use.
The IgY was precipitated from egg yolk by adding 1 volume of 40%
polyethylene glycol 8000 (Sigma) in phosphate-buffered saline (PBS) to 3
volumes of egg yolk and then centrifuged at 13,000  g for 20 min (2). The
purified IgY was then dialyzed four times with 1 liter 10 mM PBS.
Immunization of rabbits for production of rabbit anti-M. avium subsp.
paratuberculosis and anti-MAC antibody followed essentially the same protocol
as that used for chickens, with slight modification. Briefly, each rabbit was
intradermally inoculated with 500 g/ml CFA pool in an equal volume of FIA.
The subsequent three immunizations were done by subcutaneous inoculation of
250 g/ml of the CFA pool in an equal volume of FIA at 2-week intervals. After
the first and third immunizations, the serum antibody levels for each antigen
were measured by an ELISA. After the fourth immunization, serum was har-
vested from each rabbit. Rabbit IgG purification was then performed using an
ImmunoPure (G) IgG purification kit (Pierce), according to the manufacturer’s
instructions.
Both chicken IgY and rabbit IgG were pure, as evidenced by a single band by
sodium dodecyl sulfate-polyacrylamide gel electrophoresis comparable to those
of the commercial antibody controls (data not shown). The yield was 4 to 5 mg/ml
of IgY from a single egg and 10 ml of 2 to 3 mg/ml rabbit IgG by BCA assay.
Enhancement of antibody specificity. The specificity of rabbit anti-M. avium
subsp. paratuberculosis IgG and anti-MAC IgG were enhanced by absorption by
both M. phlei and Escherichia coli antigens; chicken anti-M. avium subsp. para-
tuberculosis IgY and anti-MAC IgY were enhanced by absorption with M. phlei
antigens. Briefly, 100 g of purified IgY was mixed with 107 CFU/ml of M. phlei
ATCC 11758 and incubated at 4°C overnight. The mixture was then filtered using
a 0.2-m syringe filter (Nalgen). The filtered antibody was dialyzed in 10 mM
PBS three times, and the final concentration of absorbed anti-M. avium subsp.
paratuberculosis and anti-MAC IgY was determined using the BCA protein
assay. As intact mycobacterial cells alone were not sufficient for removal of the
cross-reactivity of rabbit anti-M. avium subsp. paratuberculosis and anti-MAC
IgG with other bacteria, CEA of both M. phlei ATCC 11758 (500 g/ml) and E.
coli DH5 (200 g/ml) were used to absorb cross-reactive rabbit antibodies. Only
absorbed chicken IgY and rabbit IgG were employed in the final assay (referred
to as “chicken anti-M. avium subsp. paratuberculosis IgY” and “chicken anti-
MAC IgY” and “rabbit anti-M. avium subsp. paratuberculosis IgG” and “rabbit
anti-MAC IgG”).
Specificity of anti-MAC antibody preparations before and after absorption.
Reactivity of chicken anti-MAC IgY and rabbit anti-MAC IgG were tested by an
ELISA both before and after absorption, using multiple mycobacterial CFA and
CEA. Briefly, 2 g/ml of test antigen was coated on the wells of a 96-well plate
(Maxisorp; Nalge Nunc International, Rochester, NY) by overnight incubation at
4°C. After the wells were washed three times with wash buffer (KPL, Gaithers-
burg, MD), they were blocked with 10% normal goat serum (Sigma, St. Louis,
MO) at room temperature (RT) for 2 h. Either (i) 100 l of 2 g/ml absorbed
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or nonabsorbed anti-MAC IgY or (ii) 100 l of 1:4,000 diluted absorbed or
nonabsorbed rabbit anti-MAC IgG was added to each well and then incubated at
RT for 30 min while being shaken at 60 rpm. After the wells were washed five
times with wash buffer, horseradish peroxidase (HRP)-conjugated rabbit anti-
IgY (GenTel) at a dilution of 1:4,000 or HRP-conjugated sheep anti-rabbit IgG
(Vector) at a dilution of 1:5,000 was added to each well and incubated for 30 min
at RT. Plates were washed five times with wash buffer (KPL), after which 100 l
of TMB substrate (TMBE-500; Moss Inc., Pasadena, MD) was added to each
well, and then they were incubated for 1 min at RT. The reaction was then
stopped by addition of 100 l stop solution (KPL). The optical density (OD) of
the final reaction in each well was measured at 450 nm using an ELISA reader
(Quant; Bio-Tek Instruments Inc., Winooski, VT).
Development of optimal MAC-ELISA protocol. Critical reagents in the MAC-
ELISA are (i) the solid phase capture antibody, chicken anti-M. avium subsp.
paratuberculosis IgY; (ii) the test substance, mycobacterial broth culture fluid
potentially containing secreted MAC antigens; (iii) the detector antibody, rabbit
anti-MAC IgG; and (iv) the conjugate, HRP-conjugated goat anti-rabbit IgG
(Vector) (see Fig. 2). The concentrations and volumes of all critical antibody
components were optimized for analytical sensitivity and specificity by reagent
titration individually and in various combinations with culture fluid from pure
cultures of M. avium subsp. paratuberculosis, M. avium subsp. avium, M. avium
subsp. hominissuis, M. intracellulare, M. scrofulaceum, M. phlei, M. terrae, and
Corynebacterium pseudotuberculosis (data not shown). The final MAC-ELISA
protocol was as follows. Plates (96 well, Maxisorp; Nalge Nunc International)
were first coated with 10 g of capture antibody, chicken anti-MAC IgY, and
diluted in coating buffer (KPL) by overnight incubation at 4°C. After the wells
were washed three times with wash buffer (KPL), all wells were blocked with
10% normal goat serum (Sigma) at RT for 2 h. Medium (100 l) from the liquid
cultures to be tested was next added to each well. After 1 h at RT with shaking
(60 rpm), the plate was again washed three times with wash buffer. The detector
antibody, rabbit anti-MAC IgG (100 l of 0.5 g/ml) was added to each well and
incubated 30 min at RT. Wells were again washed three times with washing
buffer (KPL). Then, 100 l of HRP-conjugated goat anti-rabbit IgG (Vector) at
a dilution of 1:5,000 was added to all wells and incubated for 30 min at RT. Plates
then were washed five times with wash buffer (KPL). Last, 100 l TMB substrate
(TMBE-500; Moss Inc.) was added to each well and was followed by a 1-min RT
incubation, after which the reaction was stopped by adding 100 l of stop
solution (KPL) to each well. The OD of the final reaction in each well was
measured at 450 nm using an ELISA reader (Quant; Bio-Tek Instruments,
Inc.). On each plate there were two positive controls in duplicate (M. avium
subsp. paratuberculosis and MAC culture fluid) and three negative controls (PBS,
MGIT medium, and M. phlei culture fluid). The cutoff value for a positive assay
is determined as two times the mean OD of the three negative-control wells.
Analytical sensitivity and specificity of the MAC-ELISA. CF from pure liquid
cultures of both mycobacterial and nonmycobacterial strains were tested. To
estimate MAC-ELISA analytical sensitivity, twofold serial dilutions of CF (16.0
to 0.0078 g/ml) from each type strain were tested. Assay results were compared
with positive controls (culture fluid from M. avium subsp. paratuberculosis ATCC
TABLE 1. Bacterial strains used to assess specificity of MAC-ELISAc
Species or organism Total no. ofstrains
Reference strains included in
total no. tested
Sources other than
ATCCa
Detection time with
MAC-ELISA (wk)b
Mycobacterium spp.
M. avium subsp. paratuberculosis 13 ATCC 19698, K-10 JTC 3
M. avium subsp. avium 4 ATCC 35712, ATCC 25291 JTC 1 or 2
M. avium subsp. hominissuis 6 104 JTC, EPA, WSLH 1 or 2
M. intracellulare 9 ATCC 13950, ATCC 25122 JTC, EPA, WSLH 1
M. silvaticum 1 ATCC 49884 3
M. abscessus 1 ATCC 19977 N
M. asiaticum 4 ATCC 25276 JTC N
M. bovis 3 ATCC 19210 JTC N
M. celatum 4 ATCC 51130 JTC N
M. flavescens 2 ATCC 14474 JTC N
M. fortuitum 2 ATCC 49404 WSLH N
M. gordonae 2 ATCC 14470 JTC N
M. kansasii 3 ATCC 12478 JTC N
M. lentiflavum 2 ATCC 51985 WSLH N
M. malmoense 1 ATCC 29571 N
M. marinum 2 ATCC 927 WSLH N
M. nonchromogenicum 1 ATCC 19530
M. phlei 1 ATCC 11758 N
M. scrofulaceum 7 ATCC 19981 JTC N
M. simiae 2 ATCC 25275 WSLH N
M. smegmatis 2 ATCC 14468, mc2155 N
M. terrae 3 ATCC 15755 JTC N
Nonmycobacterial species
Aeromonas hydrophila 1 WSLH N
Corynebacterium pseudotuberculosis 1 JTC N
Enterococcus faecalis 1 ATCC 29212 WSLH N
Enterobacter aerogenes 1 WSLH N
Escherichia coli 4 ATCC 25922 WSLH N
Klebsiella pneumoniae 1 WSLH N
Proteus vulgaris 1 WSLH N
Pseudomonas aeruginosa 1 WSLH N
Unidentified fungi 6 JTC N
Total 92
a Isolates were identified using mutiplex PCR and HPLC. JTC, Johne’s Testing Center, Madison, WI; EPA, Environmental Protection Agency, Cincinnati, OH;
WSLH, Wisconsin State Laboratory of Hygiene, Madison, WI.
b Detection time indicates the amount of time for CFA to be completely detected in the assay, when a starting inoculum of 102 CFU/ml of all strains was cultivated
in 7H9 broth, up to 8 weeks. N, not detected.
c ATCC, American Type Culture Collection, Manassas, VA.
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19698 and M. avium subsp. avium ATCC 35712) and negative controls (culture
fluid from M. phlei and M. terrae). To determine MAC-ELISA analytical speci-
ficity and optimal timing for testing, culture fluid from 7H9 broth cultures of
mycobacteria was collected weekly, up to 8 weeks (Table 1). Briefly, 102 CFU of
each mycobacterial strain was inoculated into 10 ml of Middlebrook 7H9 broth
(Difco, Sparks, MD) supplemented with 0.5% glycerol and 10% OADC (Middle-
brook), and incubated at 37°C for 8 weeks. For M. avium subsp. paratuberculosis
strains, 2 g/ml of mycobactin J (Allied Monitor, Fayette, MO) was also added
to the culture medium for optimal growth. Nonmycobacterial strains were grown
in LB medium (Table 1). Corynebacterium pseudotuberculosis was grown in brain
heart infusion broth. Culture fluid from all strains, along with positive and
negative controls, was tested weekly by MAC-ELISA, as described above.
Assessment of MAC-ELISA versus MGIT960 ParaTB culture system for pure
cultures. Duplicate tubes of MGIT ParaTB medium (Becton Dickinson) were
inoculated with serial dilutions of M. avium subsp. paratuberculosis ATCC 19698,
M. avium subsp. avium ATCC 35712, M. phlei ATCC 11758, or M. terrae ATCC
15755. Briefly, undiluted stock cell suspension (1.0 ml) was added to 9.0 ml of 10
mM PBS (pH 7.2), and 10-fold serial dilutions were made in 10 mM PBS (pH
7.2), with vortexing between each dilution step resulting in 100 to 107 CFU/ml of
each of the four mycobacterial strains. From each dilution, 100 l was inoculated
into MGIT ParaTB medium (Becton Dickinson, Sparks, MD). Each MGIT tube
contained 7 ml of modified Middlebrook 7H9 broth base, with mycobactin J and
fluorescent indicator measuring changes in oxygen concentration embedded in
silicone on the bottom of the tube. Per the manufacturer’s instructions, each tube
was supplemented with 800 l MGIT ParaTB supplement (BD), 500 l egg yolk
(BD), and 100 l VAN antibiotic cocktail, resulting in final concentrations of 10
g/ml vancomycin, 40 g/ml amphotericin B, and 60 g/ml nalidixic acid. All
MGIT ParaTB medium tubes were incubated at 37°C in a MGIT 960 instrument.
Tubes were removed when the machine signaled them positive, based on changes
in the indicator. For each MGIT-positive tube, culture fluid (100 l) was then
tested by a MAC-ELISA, with results analyzed in relationship to the time to
detection (incubation time in days until signal positive) for each culture.
Preliminary assessment of the MAC-ELISA using well-defined clinical cul-
tures. A total of 1,275 animal fecal, tissue, water, and soil samples yielding
acid-fast stain-positive organisms were tested using the MAC-ELISA. This set
was obtained from 684 clinical cultures in modified Bactec 12B medium and 591
clinical cultures in MGIT ParaTB medium. Once a liquid culture instrument
signaled positive, acid-fast staining was done on the cultures and contamination
was checked by inoculation into 5% sheep blood agar plates. Final identification
of mycobacterial isolates was done using as a reference method a multiplex PCR
simultaneously targeting mycobacterial 16S DNA and four insertion elements,
IS900, IS901, IS1311, and IS1245 (Johne’s Testing Center, Madison, WI), with
reference strains as controls. Ultimately these 1,275 clinical samples yielded 340
MAC and 344 non-MAC mycobacteria from modified Bactec 12B medium and
305 MAC and 286 mycobacteria other than MAC from MGIT ParaTB medium.
The optimal cutoff, sensitivity, and specificity of the MAC-ELISA were deter-
mined by receiver operator characteristic (ROC) curve analysis.
Validation of the MAC-ELISA to triage MGIT signal-positive cultures. Pro-
spectively, 652 consecutive clinical samples (animal feces, tissues, water, or soil)
were processed for M. avium subsp. paratuberculosis isolation according to the
manufacturer’s recommendations using the MGIT ParaTB medium. The first
time the MGIT 960 instrument signaled a tube “positive,” it was removed from
the instrument, vortexed, and reinserted in the machine. After the tube signaled
positive a second time (or if it signaled positive within 1 week of the 49-day
incubation protocol), the MAC-ELISA was performed. For MAC-ELISA-neg-
ative cultures, acid-fast staining (Ziehl-Neelsen) on culture fluid smears inde-
pendently assessed the presence of mycobacteria. The multiplex PCR was used
to verify the identity of mycobacteria in all acid-fast stain-positive and MAC-
ELISA-positive MGIT cultures. In any cases of discrepancy between MAC-
ELISA and multiplex PCR results, two assays were used to clarify the true
identity of mycobacterial isolates: IS900 nested PCR for M. avium subsp. para-
tuberculosis (greater analytical sensitivity than the multiplex) and HPLC of cell
wall mycolic acids for all other mycobacteria (Wisconsin State Laboratory of
Hygiene, Madison, WI) (14).
Statistical analysis. Specificity and sensitivity were evaluated by ROC curves.
MAC-ELISA OD values before and after antibody absorption were compared by
the t test. Differences in OD values between MAC cultures and cultures with
mycobacteria other than MAC were compared by the Mann-Whitney test. Sta-
tistical analyses were done using statistical software (GraphPad Prism version
4.03 for Windows; GraphPad Software, San Diego CA).
RESULTS
Anti-MAC antibody specificity. Prior to absorption with het-
erologous antigens, both chicken anti-M. avium subsp. paratu-
berculosis IgY and anti-MAC IgY showed cross-reactivity to
other mycobacteria, such as M. scrofulaceum, M. phlei, and M.
terrae. After absorption with M. phlei cells, the cross-reactivity
to those mycobacteria disappeared without significant decrease
in reactivity (ELISA OD) to target M. avium subsp. paratuber-
culosis and MAC mycobacteria (Fig. 1A). Rabbit anti-MAC
IgG and anti-M. avium subsp. paratuberculosis IgG both cross-
reacted with nonmycobacteria as well as all mycobacteria
tested. After absorption with the CEA from M. phlei and E.
coli, however, this cross-reactivity decreased significantly with-
out appreciable change in reactivity to secreted antigens of M.
avium subsp. paratuberculosis or MAC (Fig. 1B). The absorbed
chicken and rabbit anti-MAC and anti-M. avium subsp. para-
tuberculosis retained strong reactivity to both MAC and M.
FIG. 1. Comparison of single antibody cross-reactivity pre- and postabsorption. Chicken anti-MAC IgY (A) and rabbit anti-MAC IgG (B).
Lanes for both panels: 1, Mycobacterium avium subsp. paratuberculosis ATCC 19968; 2, Mycobacterium avium subsp. avium ATCC 35712; 3,
Mycobacterium intracellulare ATCC 25122; 4, Mycobacterium phlei ATCC 11758; 5, Mycobacterium terrae ATCC 15755; 6, Mycobacterium scrofu-
laceum ATCC 19981; 7, Corynebacterium pseudotuberculosis clinical isolate; 8, Escherichia coli ATCC 25922; 9, a mixture of environmental bacteria,
including Aeromonas hydrophila, Enterobacter aerogenes, Enterococcus faecalis, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Proteus
vulgaris.
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avium subsp. paratuberculosis and moderate reactivity to M.
intracellulare and could not distinguish among these members
of the MAC.
Development of MAC-ELISA. Numerous combinations and
concentrations of chicken and rabbit anti-M. avium subsp.
paratuberculosis and anti-MAC were tested during develop-
ment of the MAC-ELISA. The combination providing optimal
sensitivity and specificity for detection of secreted MAC anti-
gens in liquid cultures required use of chicken anti-M. avium
subsp. paratuberculosis IgY for antigen capture and rabbit anti-
MAC IgG for captured-antigen detection, together with a suit-
able commercial conjugate to detect rabbit antibody binding
(data not shown) (Fig. 2). Although the antibodies were pro-
duced using selected subspecies of the MAC, they did not
discriminate among MAC subspecies nor between M. avium
and M. intracellularae. The final assay is thus complex specific,
but not species or subspecies specific, and therefore is referred
to as the MAC-ELISA.
MAC-ELISA specificity and sensitivity for pure cultures.
Culture fluid obtained weekly from 92 mycobacterial and non-
mycobacterial strains were tested. After 8 weeks of incubation,
no mycobacteria outside the MAC triggered a positive MAC-
ELISA (Table 1). All MAC members (13 M. avium subsp.
paratuberculosis, 4 M. avium subsp. avium, 6 M. avium subsp.
hominissuis, 1 M. avium subsp. silvaticum, and 9 M. intracellu-
larae strains) became MAC-ELISA positive between 1 and 4
weeks of incubation in Middlebrook 7H9, when the starting
inoculum was 102 CFU. The specificity and sensitivity of the
MAC-ELISA were enhanced by use of absorbed antibodies
(Fig. 3). Assay accuracy using anti-M. avium subsp. paratuber-
culosis IgY for antigen capture and anti-MAC IgG for antigen
detection was superior to all other antibody combinations
(data not shown). The MAC-ELISA analytical sensitivity was
0.03125 g/ml M. avium subsp. paratuberculosis CFA (Fig. 3B)
and 0.0625 g/ml M. avium subsp. avium CFA (Fig. 3C) when
two times the negative-control OD (M. phlei culture fluid) was
used as the cutoff for a positive test.
Optimal incubation time for detection and detection limit.
Time to detection as reported by the MGIT 960 instrument
FIG. 2. Schematic diagram of the MAC-ELISA procedure. Key
reagents for each step of the MAC-ELISA are indicated in the figure
key. MAP, Mycobacterium avium subsp. paratuberculosis; O.D., optical
density.
FIG. 3. Analytical sensitivity of the MAC-ELISA. (A) Enhanced
specificity and sensitivity of the MAC-ELISA by absorption of chicken
anti-M. avium subsp. paratuberculosis IgY capture antibody and rabbit
anti-MAC IgG detector antibody. Lanes: 1, Mycobacterium avium
subsp. paratuberculosis ATCC 19968; 2, Mycobacterium avium subsp.
avium ATCC 35712; 3, Mycobacterium intracellulare ATCC 25122; 4,
Mycobacterium phlei ATCC 11758; 5, Mycobacterium terrae ATCC
15755; 6, Mycobacterium scrofulaceum ATCC 19981; 7, Corynebacte-
rium pseudotuberculosis clinical isolate; 8, Escherichia coli ATCC
25922; 9, a mixture of environmental bacteria, including Aeromonas
hydrophila, Enterobacter aerogenes, Enterococcus faecalis, Klebsiella
pneumoniae, Pseudomonas aeruginosa, and Proteus vulgaris. (B) Ana-
lytical detection limit of the MAC-ELISA using purified M. avium
subsp. paratuberculosis (MAP) CFA. (C) Analytical detection limit of
the MAC-ELISA using purified M. avium subsp. avium (MAA) CFA.
VOL. 16, 2009 SCREENING METHOD FOR MAC DETECTION IN LIQUID CULTURE 617
and incubation time to positive MAC-ELISA were similar,
given that the MGIT instrument read cultures hourly and cul-
ture fluid was tested by the MAC-ELISA only weekly. The
MAC-ELISA detection limit for M. avium subsp. paratubercu-
losis and MAC was 101 CFU/ml. Culture fluid from M. phlei
never triggered a positive MAC-ELISA (Table 2).
ROC analysis of the MAC-ELISA using well-defined clinical
cultures. A significant difference in MAC-ELISA OD values
was observed between clinical cultures containing MAC and
non-MAC mycobacteria (P  0.0001) (Fig. 4A). The cutoff
value for maximum assay accuracy was determined by ROC
curve analysis. The assay sensitivity and specificity were 92.6%
(95% confidence interval [95% CI], 90.3 to 94.5) and 99.9%
(95% CI, 99.2 to 100), respectively, with an area under the
ROC curve (AUC) of 0.992 (Fig. 4B).
Clinical application of MAC-ELISA. The MGIT 960 instru-
ment signaled growth in 652 clinical cultures; MAC-ELISA
indicated that MAC species were present in 219 (33.6%) of
them. Among these 219 cultures, 212 were confirmed as
containing MAC organisms (96.8% [210 M. avium subsp. para-
tuberculosis and 2 MAC]). The other seven were found to
contain mycobacteria other than MAC, for a false-positive
MAC-ELISA rate of 3.2% (7/219) (Fig. 5).
The remaining 433 MGIT-positive cultures were MAC-
ELISA negative (66.4%). Of these, 426 (98.4%) did not con-
tain acid-fast bacteria, suggesting a high rate of false-positive
signals by the MGIT system. Seven of the 433 MGIT-positive
but MAC-ELISA-negative cultures (1.6%) had acid-fast bac-
teria identified as M. avium subsp. paratuberculosis (n  6) or
non-MAC mycobacteria (n  1), resulting in a false-negative
rate of 6/433 (1.4%) (Fig. 5). More than 500 MGIT signal-
negative cultures as well as uninoculated culture medium were
also MAC-ELISA negative (data not shown).
FIG. 4. Preliminary assessment of the MAC-ELISA using 1,275 well-defined clinical cultures. (A) Scatter plot (left) of MAC-ELISA OD values
for MAC and mycobacteria other than MAC. Each spot represents the MAC-ELISA OD value for a single culture, and the horizontal bar
represents the mean OD of the group. Bar and whisker plot (right) of MAC-ELISA OD values. The boxes represent standard errors of the
means, and the error bars represent 95% CIs. (B) ROC analysis of the scatter plot data. AUC, area under the curve.
TABLE 2. Comparison of time to positive culture between
MAC-ELISA and MGIT cultures
Inoculum
CFU/ml
Time to positive culture (days)c
M. avium subsp.
paratuberculosis
JTC303
M. avium subsp.
avium ATCC
35712
M. phlei ATCC
11758
MGITa MAC-ELISAb MGIT
MAC-
ELISA MGIT
MAC-
ELISA
106–107 4.8 7 3.5 7 0.7 ND
105–106 7.2 7 5.3 7 2.6 ND
104–105 10.1 14 6.9 7 4.3 ND
103–104 12.8 21 8.7 14 6.0 ND
102–103 17.1 21 10.6 14 10.4 ND
101–102 21.5 28 12.7 21 14.8 ND
100–101 39.1 35 15.8 21 ND ND
101–100 ND ND ND ND ND ND
a The MGIT 960 instrument measures fluorescence as an indication of micro-
bial growth hourly.
b Culture fluid was tested by the MAC-ELISA weekly.
c ND, not detectable by the MAC-ELISA up to 56 days of incubation.
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DISCUSSION
Antibodies produced by immunization of chickens or rabbits
with MAC or M. avium subsp. paratuberculosis CFs yielded
high titers of purified anti-mycobacterial egg yolk IgY or serum
IgG, respectively. The specificity of these antibody prepara-
tions for MAC mycobacteria was significantly enhanced by
absorption with antigens from heterologous organisms: M.
phlei for the chicken IgY and both M. phlei and E. coli for
rabbit IgG. These antibodies proved useful reagents in the
design of a highly specific assay for MAC antigens secreted
during culture in liquid media: Middlebrook 7H9, WR, mod-
ified Bactec 12B, or MGIT ParaTB medium.
Identification of MAC at the subspecies level would be clin-
ically relevant because of differences in epidemiology and
pathogenicity (6, 35). However, members of the MAC have
few reliable phenotypic characteristics that allow identification
by conventional methods. Even the most common reference
method for mycobacterial identification, HPLC chromato-
grams of mycolic acid cell wall extracts, fails to reliably distin-
guish among MAC subspecies (10, 35).
Automated liquid culture systems, such as Bactec 460,
MGIT 960, Trek ESP II, and BacT/ALERT, in combination
with specific specimen-processing protocols, are designed to
triage clinical cultures, that is, distinguish cultures that contain
microorganisms of interest from those that do not. The goal of
such systems is to help clinical laboratories focus organism
identification resources on those cultures with the highest
probability of containing clinically relevant mycobacterial
pathogens.
The MAC-ELISA is an effective tool for selecting MGIT
ParaTB medium cultures for additional testing by PCR; 96.8%
of 219 cultures so selected contained MAC mycobacteria,
while only 6 of 652 MGIT-positive cultures (0.9%) were MAC-
ELISA false negative (Fig. 5). With the panel of clinical sam-
ples evaluated, use of the MAC-ELISA to screen MGIT-pos-
itive cultures before application of PCR correctly avoided
unnecessary PCR testing of 64.3% (419) of MGIT signal-pos-
itive cultures. Acid-fast staining of cultures is also effective at
culture screening but is more labor-intensive, requires techni-
cal skill, and is not objective. A limitation of the study was that
clinical samples were from animals being assessed for Johne’s
disease and thus strongly biased toward recovery of M. avium
subsp. paratuberculosis. Further evaluation in a human clinical
mycobacteriology laboratory setting is necessary. The MAC-
ELISA may provide a low-cost, rapid, objective, sensitive, and
specific test for MAC in signal-positive cultures in automated
mycobacterial detection systems.
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